In our first article, we introduced five KPIs that specialist practices should be measuring but usually aren't. In our second, we showed how to capture referrals that disappear before they ever reach a consultation chair. This time, we're tackling the metric everyone thinks they understand: case acceptance.

Specifically, we're going after three assumptions that are quietly costing specialist practices hundreds of thousands of dollars a year.

Assumption 1: Higher case acceptance is always better.

Assumption 2: Same-day acceptance is the goal.

Assumption 3: Where and how you present treatment doesn't matter.

All three assumptions are wrong.

The hamster wheel

Practices with consistently high case acceptance rates tend to share a pattern. Their average case value is low.

The math is straightforward. The easiest way to get a patient to say yes is to present something small—phase 1 treatment, e.g., the single extraction instead of the full-arch reconstruction or the limited perio plan instead of the comprehensive case. Patients say yes because the financial and emotional commitment is manageable. The coordinator looks great on paper. And the schedule stays full.

But full doesn't mean profitable. A coordinator converting at 95% with an average case value of $2,800 is producing less per patient than a coordinator converting at 72% with an average case value of $4,200. Run the math across 100 consults. The 95% coordinator generates $266,000 in accepted treatment. The 72% coordinator generates $302,400. The "lower performer" outproduces the “all-star” by over $36,000.

This is the hamster wheel. Busy schedules. Packed operatories. Disappointing production numbers. You're working harder to stay in the same place because you're capturing volume instead of value.

Comprehensive doesn't mean aggressive

Comprehensive treatment presentation means showing the patient the full scope of what they need and letting them make an informed decision.

A patient referred for a single implant may also need bone grafting, soft tissue work, and a final restoration. The conservative approach presents the implant only. Maybe it mentions the graft. It defers the rest to "later." The patient says yes, the case moves forward, and six months from now you're presenting additional treatment that should have been part of the original plan.

The comprehensive approach presents all of it upfront. Here's what you need. Here's why. Here's what it costs. Here's how we sequence it if you need to spread it out.

Some patients will say no. That's fine. A "no" to a $12,000 comprehensive plan isn't a failure. It's an opportunity sitting in your follow-up pipeline. And that pipeline is where a disproportionate share of your production actually lives.

Where you present changes what patients decide

Most practices don't track where the financial conversation happens. They should.

When we work with practices that segment their presentation data by location, the results are consistent and significant. Chairside presentations, desk-side presentations, dedicated treatment coordinator rooms, and remote or phone-based presentations all produce different conversion rates, different average case values, and different production per consultation numbers.

The differences aren't subtle. We've seen 15% to 20% swings in conversion rate between presentation locations within the same practice, using the same coordinators, presenting the same case types. The variable wasn't the person or the treatment plan. It was the environment.

A patient still in the chair, still processing what the doctor just told them, responds differently to a financial conversation than a patient who's been walked to a private room, seated comfortably, and given time to absorb. Neither setting is universally better. The point is that you can't optimize what you don't measure, and most practices don't measure this at all.

The fix isn't complicated. Track presentation location as a variable for 30 days. Compare conversion, average case value, and production per consultation across locations. Then adjust. Test desk-side versus TC room for large cases. Test chairside for routine procedures. Treat your practice like a workbench. Run the experiment, read the data, iterate. Nothing has to be permanent. Everything should be tested.

The same-day myth

The conventional wisdom in specialist practices is clear: close the case today. Get the yes before the patient walks out the door. Same-day acceptance is the metric that matters. Same-day acceptance is the engine of daily production. But when it becomes the only metric you optimize for, it distorts everything downstream.

Here's what the data shows across hundreds of practices. Same-day acceptance typically runs around 45%. Total acceptance after 90 days climbs to 68%. That 23-point spread is delayed conversion—patients who walked out undecided and came back because someone followed up.

Now here's the insight most practices miss: the average case value of delayed acceptances is significantly higher than same-day acceptances. A $2,000 extraction gets accepted on the spot. An $8,000 implant case takes a phone call two weeks later and a second conversation about financing options. A $15,000 full-arch case might take two months and three touchpoints. The cases that take time are the cases worth the most.

If your team is trained to "always close same-day," they will naturally default toward presenting smaller cases that patients can agree to immediately. They're not doing it intentionally. They're responding to the incentive. And the incentive is the metric you chose.

When same-day and total are too close

If your same-day acceptance rate and your total acceptance rate are within five points of each other, something is broken. Either your team isn't following up on undecided patients, or you're only presenting cases small enough to get immediate yeses. Both explanations lead to the same outcome: you're leaving your highest-value cases on the table.

Practices with healthy follow-up systems typically see a 10 to 15 point spread between same-day and total acceptance. That gap represents patients who needed time but ultimately said yes. It represents the ROI of having someone whose job is to follow up. And in hard dollars, it often represents $200,000 to $400,000 in annual production that would otherwise evaporate.

When 90%+ deserves a second look

A 90%+ case acceptance rate can be legitimate. If your tracking is airtight, every referral is logged, every presentation is documented, and every undecided patient is accounted for, then a high number might simply mean your team is excellent at what they do. That's worth celebrating.

But here's the question worth asking: how confident are you in the denominator?

Case acceptance is a fraction. The numerator is patients who said yes. The denominator is patients who were presented treatment. If the denominator only includes patients who were already leaning yes, the percentage looks great but doesn't reflect reality. The patients who called and couldn't get in, the ones who came to consult but left without a formal presentation, the ones sitting in a folder somewhere, they're not in your denominator. And that makes 90% a lot less meaningful.

This isn't about doubting your team. It's about trusting your data. The practices that genuinely run high acceptance rates can prove it because they track everything. They know their schedule rate, their pending pipeline, their follow-up conversion, and their average case value. The 90% holds up because the whole picture holds up.

Where it becomes a concern is when high acceptance lives alongside low average case value. That combination usually means presentations are being scoped down to guarantee yeses. A coordinator hitting 93% with a $2,800 average case value is likely presenting too conservatively. The patients who needed comprehensive treatment are coming back for phase two and phase three in separate visits, fragmenting revenue and filling the schedule with follow-up instead of high-value new cases.

The other pattern to watch for is when same-day acceptance and total acceptance are nearly identical at 90%+. If delayed conversion is close to zero, either follow-up isn't happening or the cases being presented are small enough that every patient decides on the spot. Either way, the number deserves scrutiny.

PPH: The metric that resolves everything

Acceptance rate alone is misleading. Average case value alone is incomplete. You need both, combined into a single number that tells you how efficiently each coordinator converts opportunity into production.

We call it PPH: Projected production per 100 consults. The formula is simple: acceptance rate multiplied by average case value, projected across 100 consultations.

Coordinator A: 74% acceptance × $3,643 average case value = $269,582 per 100 consults.

Coordinator B: 88% acceptance × $2,100 average case value = $184,800 per 100 consults.

Coordinator B looks better on every traditional report. But Coordinator A produces 46% more revenue per consultation. PPH resolves the tension between conversion rate and case value. It tells you who's actually producing, not who's collecting the most yeses.

When you start tracking PPH alongside acceptance rate, your coaching conversations change. Instead of pushing everyone toward higher acceptance, you start asking better questions:

• Which case types does this coordinator excel at?
• Where does acceptance drop as case value increases?
• Is that a training gap or a natural strength to leverage?

Giving every case a fair window

Standard reporting has a fundamental flaw. A case presented yesterday gets one day to convert. A case from last quarter gets 90 days. Comparing them isn't fair, and the numbers lie.

The fix is giving every case the same evaluation window. We recommend 90 days. Cases older than 90 days are "fully baked." Recent cases are still baking. Don't mix them together.

When you separate baked months from still-baking months, you see your real same-day rate and your real delayed rate without recency bias. You can track trends that actually mean something. And you can spot when delayed conversion starts dropping, weeks before production feels the impact.

This approach also proves the ROI of follow-up in a way doctors respond to. When you can show that the delayed window between 30 and 90 days added $25,000 in accepted treatment last month, the conversation about investing in a follow-up coordinator becomes simple math.

Building the follow-up system

The practices that convert delayed cases don't rely on memory. They build systems.

When a patient leaves without accepting treatment, someone needs to own what happens next. Not informally. Not "we'll try to call them." There should be a documented process where every undecided patient gets assigned to a specific person with a specific follow-up date. If your system allows a patient to leave undecided with no one responsible for the next contact, patients will fall through the cracks. 

The default cadence is simple: reach out at two days, two weeks, and two months. After three documented attempts with no response, close the case and notify the referring doctor.

But follow-up cadence should scale with case value. A $2,000 case gets the standard three-touch profile. A $20,000 full-arch case gets a longer, more persistent profile with additional touchpoints extending out to six months or more. The patient who declines today may not be ready until insurance resets, a tax refund arrives, or the temporary solution fails. Your job is to be there when that moment comes.

Duration beats frequency. Don't call a patient three times in two weeks and then abandon them. Spread the touches over months. Stay present without pestering. The practices that understand this distinction recover significantly more revenue than the ones chasing quick closes.

Your next step

Pull your case acceptance data for the last 120 days. Look at three numbers: same-day acceptance, total acceptance, and the gap between them. If that gap is less than five points, your follow-up system isn't working or your presentations are too small.

Calculate PPH for each coordinator. You may find your rankings flip. Start tracking presentation location if you aren't already. Pick one variable, test it for 30 days, and compare.

Then check how many undecided patients are sitting in your system right now without a follow-up task assigned. Every one of them said "not yet," not "no." The difference is revenue waiting to happen.

Strategic treatment presentation isn't about closing harder. It's about presenting comprehensively, measuring honestly, and building systems that stay with patients until they're ready. The same-day close is important. It just isn't the whole story.